Conferences  >  Medicine & Healthcare  >  Hematology  >  United States

Binaytara Foundation

This CME-accredited activity “Multiple Myeloma & Lymphoma Summit” features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to, CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Event and Communication Assistant;     Phone: [4255575953];     Email: tiani.g@binayfoundation.org

conference, CME, continuing education, oncology, utah, cancer research, healthcare equity

Oncology,    Continuing Medical Education (CME)

Binaytara Foundation

CME-accredited oncology conference being held in person in Seattle, WA. This conference features lectures and discussions with leading experts in cellular therapies. The goal of this oncology conference is to improve the knowledge, competence, and performance of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients receiving cellular therapies for hematologic and non-hematologic disorders. The conference agenda includes an in-depth discussion and analysis of the latest scientific findings and practice-changing advances in chimeric antigen receptor (CAR) based therapies. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Event Planner;     Phone: [4255575953];     Email: support@binayfoundation.org

CLL/NHL, ALL, MULTIPLE MYELOMA, SOLID TUMORS, SUPPORTIVE CARE

Oncology,    Continuing Medical Education (CME)

Bio Ascend LLC

The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts—from laboratory-based research to the clinic—in the pathobiology and treatment of these blood cancers. The biennial meeting is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders in one location for 4 days every other year.

Chronic lymphocytic Leukemia, ( CLL)

Continuing Medical Education (CME),    Oncology